Commerzbank Boosts Stake in Biotech Giant Amgen Inc.
Commerzbank Aktiengesellschaft FI acquired an additional 14,693 shares of Amgen Inc. (NASDAQ:AMGN) in the second quarter, increasing its holdings by 7.5%. This brought the company's total ownership to 209,478 shares, accounting for approximately 1.5% of Commerzbank Aktiengesellschaft FI's portfolio.
The value of these shares was $75,856,000 as of the most recent SEC filing. Amgen Inc. is a global biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutic products.